1Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention[J]. Arthritis Rheum, 1998, 41(8): 1343-1355. 被引量：1
3Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis[J]. Cochrane Database Syst Rev, 2006(1): CD004257. 被引量：1
4Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs[J]. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-S30. 被引量：1
5Hochberg MC, Altman RD, April KT, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee[J]. Arthritis Care Res (Hoboken), 2012, 64(4): 465-474. 被引量：1
6Langman M J, Jensen DM, Watson D J, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs[J]. JAMA, 1999, 282(20): 1929-1933. 被引量：1
7Anon. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines[J]. Arthritis Rheum, 2000, 43(9): 1905-1915. 被引量：1
8Anon. The management of chronic pain in older persons: AGS Panelon Chronic Pain in Older Persons. American Geriatrics Society[J]. J Am Geriatr Soc, 1998, 46(5): 635-651. 被引量：1
9Biswal S, Medhi B, Pandhi P. Longterm efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: metaanalysis of randomized placebo controlled clinical trials[J]. J Rheumatol, 2006, 33(9): 1841-1844. 被引量：1
10Lin J, Zhang W, Jones A, et al. Efficacy of topical non-steroidal anti- inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials[J]. BMJ, 2004, 329(7461): 324. 被引量：1
二级参考文献18
1Guccione AA, Felson DT, Anderson JJ, et al: Specific disease and their effects on functional limitations in elders in the Framingham Study. Am J Public Health, 1994, 84:351-358. 被引量：1
2Zhang N, Shi Q, Zhang X. An epidemiologic study of knee osteoarthritis. Chung-Hua Nei Ko Tsa Chih Chinese J Int Med, 1995, 34:84-87. 被引量：1
3Hoaglund FT, Yau ACMC, Wong WI. Osteoarthritis of the hip and other joints in southern Chinese in Hong Kong. J Bone Joint Surg Am, 1973, 55:545-547. 被引量：1
4Feoson DT, Naimark A, Anderson J, et al. The prevalence of knee osteoarthritis in the elderly; the Framingham Osteoarthritis Study. Arthritis Rheum, 1987,30:914-918. 被引量：1
5Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis, 1957,16:494-501. 被引量：1
6Croft P, Cooper C, Wickham C, et al. Defining osteoarthritis of hip for epidemiologic studies. Am J Epidemiol, 1990, 132:514-522. 被引量：1
7Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum, 1986, 29:1039-1049. 被引量：1
8Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum, 1991, 34:505-514. 被引量：1
9Lawrence RC, Helmick CG, Arnett FC, et al. Prevalence estimates of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum, 1998, 41:778-799. 被引量：1
10Zhang Y, Xu L, Nevitt MC, et al. Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: The Beijing Osteoarthritis Study. Arthritis Rheum, 2001 Sep, 44:2065-2071. 被引量：1
7Takeuchi K, Tanaka A, Kato S, et al. Development of NSAID-induced small intestinal lesions-pathogenic role of COX inhibition[J].Nihon Yakurigaku Zasshi,2012, 39(3): 103-108. 被引量：1
8Bijlsma JW, Berenbaum F, Lafeber FP. Teoarthritis: an update withrelevance for clinical practice[J]. Lancet, 2011,377(9783): 2115-2126. 被引量：1
